Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Treatments Today, Emerging Treatments for Tomorrow

    Contains 1 Component(s) Includes a Live Event on 05/24/2019 at 12:00 PM (EDT)

    The overall goal of this educational initiative is to improve risk assessment and diagnosis of patients with ATTR-CM in clinical practice and guide referring physicians on how to make a timely and informed diagnosis and referral to amyloid experts.

    Important: One registrant per device; only registrant can claim CME.

    Moderators: Prem Soman, MD, PhD, MASNC and Sharmila Dorbala, MD, MPH, FASNC 

    Agenda:

    1. Clinical pearls in the management of ATTR cardiomyopathy: Rodney Falk, MD
    2. Emerging therapies for ATTR cardiomyopathy: Mathew Maurer, MD
    3. Discussion: All faculty

    Overall goal: To improve risk assessment and diagnosis of patients with ATTR-CM in clinical practice and guide referring physicians on how to make a timely and informed diagnosis and referral to amyloid experts.  

    Learning Objectives:

    • Describe current approaches for managing patients with cardiac amyloidosis
    • Demonstrate understanding of current and emerging treatments for patients with ATTR-cardiac amyloidosis

    Acknowledgement of Commercial Support This activity is supported by an educational grant from Pfizer.

    Need statement: ATTR-CM, a type of CA, caused by the accumulation of misfolded transthyretin amyloid fibrils leads to dysrhythmias and heart failure.1 Diagnosis  is often  delayed and prognosis is poor.1,2 Transthyretin CA (ATTR-CA) has two main subtypes: hereditary/mutant ATTR, and senile, or wild-type, ATTR seen mostly in patients with advancing age.3 Differentiation of ATTR-CA from light chain CA is important  to ensure appropriate treatment and management ATTR-CM is an increasingly recognized etiology of heart failure with preserved ejection fraction 4 Traditional therapies for heart failure provide systematic treatment but do not address the underlying disease, and in some instances, may even be detrimental. Hence, early and accurate diagnosis is of critical importance. 

    Lack of awareness and suspicion of CA, and because clinical presentation often overlaps with other more common cardiovascular diseases, leads to missed and/or delayed diagnosis.5 The limited specificity of echocardiography and the need for endomyocardial biopsy also delays diagnosis.

    Non-invasive imaging with technetium-99m pyrophosphate and new and emerging therapies have the potential to diagnose the disease early and improve the long-term prognosis of patients with ATTR-CM.1,6,7,8 Clinicians need to distinguish the signs and symptoms of CA from other cardiovascular diseases, provide early and accurate diagnosis differentiating the subtype, and understand both current and emerging treatments to optimize patient care, limit organ damage and improve long-term outcomes.1,6

    References:

    • Ruberg FL, et al. Circulation. 2012;126:1286-1300.
    • Ruberg FL, et al. Am Heart J. 2012;164:222-228.
    • Falk RH. Circulation. 2011;124:1079–1085.
    • Vranian MN, et al. Curr Cardiol Rep. 2015;17:100.
    • White JA, et al. Curr Cardiol Rep. 2016;18:77.
    • Gillmore JD, et al. Circulation. 2016;133(24):2404-2412.
    • Maurer M, et al. Circulation. 2017;135:1357-1377. 
    • Maurer MS, et al. N Eng J Med. 2018; 379:1007-1016.

    Important: One registrant per device; only registrant can claim CME.

    Sharmila Dorbala, MD, MPH, FASNC, Chair, Co-moderator
    Director, Nuclear Cardiology
    Brigham and Women's Hospital, Department of Radiology
    Boston, MA

    Prem Soman, MD, PhD, FRCP, FACC, MASNC, Co-moderator
    Associate Professor of Medicine (Cardiology)
    Director, Nuclear Cardiology
    Director, Cardiac Amyloidosis Center
    Director, Advanced Cardiac Imaging Fellowship
    University of Pittsburgh
    Department of Medicine
    Pittsburgh, PA

    Rodney H. Falk, MD - Presenter
    Associate Professor, Harvard Medical School
    Cardiovascular Medicine
    Director, Cardiac Amyloidosis Program
    Brigham and Women’s Hospital
    Boston, MA

    Mathew S. Maurer, MD - Presenter
    Professor of Medicine
    Director, Cardiac Amyloidosis Program
    New York Presbyterian Hospital/Columbia University Medical Center
    New York, NY

    Agenda
    Moderators:
    Prem Soman, MD, PhD, FRCP, FACC, MASNC and Sharmila Dorbala, MD, MPH, FASNC

    • Clinical pearls in the management of ATTR cardiomyopathy: Rodney Falk, MD
    • Emerging therapies for ATTR cardiomyopathy: Mathew Maurer, MD
    • Discussion: All faculty

    Objectives

    • Describe current approaches for managing patients with cardiac amyloidosis
    • Demonstrate understanding of current and emerging treatments for patients with ATTR-cardiac amyloidosis

    Planners
    Sharmila Dorbala, MD, Chair
    Linda Giering, ASNC Staff
    Wendy Passerell, ASNC Staff 

    Reviewer
    Maria Sciammarella, MD

    Disclosure Policy
    As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s 2004 Standards for Commercial Support.  In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through the disclosure of relevant financial relationship with commercial companies and resolution of conflicts of interest.  The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers and presenters involved with this activity were required to disclose any relevant financial relationships. The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and resolved or managed all identified conflicts of interest through a peer review process.

    The following faculty planners, reviewers, editors, question writers and staff reported no financial relationships:
    Maria Sciammarella, MD, Reviewer
    Linda Giering, ASNC Staff
    Wendy Passerell, ASNC Staff

    The following faculty planners, reviewers, editors, question writers and staff reported financial relationships:
    Sharmila Dorbala, MD: Consulting – Pfizer, GE Healthcare, Advanced accelerator applications, Proclara
    Prem Soman, MD: Research Grants – Astellas, Pfizer; Advisory Board – Alnylam, Talaria, Pfizer, Ionis
    Rodney Falk, MD: Research Grant – Akcea; Consulting – Akcea, Alnylam, Prothena, Pfizer
    Mathew Maurer, MD:
    Research Grants – Pfizer, Eidos, NHLBI; Advisory Board – Pfizer, Alnylam, Akcea, GSK, Eidos

    Off Label Use
    Presentations may include discussion of drugs or devices, or uses of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented.  Presenters are required to disclose to the learners, if there is any off-label usage within the presentation.

    Important: One registrant per device; only registrant can claim CME.

    Accreditation and Continuing Education Credit

    Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The American Society of Nuclear Cardiology designates this internet enduring activity for a maximum of 1 AMA PRA Category 1CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Processing Fees
    ASNC members may claim continuing education credits at no charge.  Non-members will be charged $75.00 per activity.

    Method of Participation
    This internet enduring material is a 60-minute webinar. In order to be eligible for CME credit, you must complete a pre-test, listen to the webinar, reflect on the material and respond to the post-test. A score of 75% or higher is needed to pass the post-test. You have unlimited attempts to pass. After successfully completing the pre-test, activity, post-test and evaluation form, users will be able to generate a CME certificate.

    It is estimated that this activity will take 1 hour to complete.

    This is available as an online activity with audio synchronized with PowerPoint presentations.

    Policy of Privacy and Confidentiality
    ASNC will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. ASNC may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. Click here to view ASNC’s Privacy Policy. 

    ASNC Copyright Information
    Please see the “Terms of Use” at the bottom of any asnc.org web page.

    Acknowledgement of Commercial Support 
    This activity is supported by an educational grant from Pfizer.

    Learners’ Bill of Rights 
    Please click to access Learners’ Bill of Rights.

    Contact Information
    For technical assistance or information, please contact CECity at lifetimesupport@premierinc.com 

    For questions regarding CME content or obtaining CME credit, please contact the American Society of Nuclear Cardiology at info@asnc.org. 

    Important: One registrant per device; only registrant can claim CME.

  • IAEA-ASNC webinar on Heart Failure

    Contains 1 Component(s) Recorded On: 02/14/2019

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the first in a series of complimentary webinars. These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    image

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the first in a series of complimentary webinars. These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.  

    Myocardial Perfusion Imaging Assessment of LV Mechanical Dyssynchrony to Guide Treatment in patients in Heart Failure

    The first part of the webinar will provide an overview of established and exciting, new applications of radionuclide imaging in heart failure. In the second part the speaker will describe how ECG-gated Myocardial Perfusion SPECT imaging is used to measure the regional onset of mechanical contraction as an indicator of LV intraventricular dyssynchrony (LVD). The session will also address how biventricular pacemakers are being used to treat systolic heart failure in patients with advanced left bundle branch block using Cardiac Resynchronization Therapy (CRT) and the role that LVD plays in predicting CRT response and assessing treatment. The potential of this use of LVD will be discussed under the results of the IAEA funded VISION-CRT study.

    Faculty:

    Prem Soman, MD, PhD, MASNC
    Associate Professor of Medicine (Cardiology) and Clinical & Translational Science
    Director, Nuclear Cardiology
    Director, Multidisciplinary Cardiac Amyloidosis Center
    University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

    Ernest V. Garcia, PhD, MASNC
    Professor of Radiology and Imaging Sciences
    Director, Emory Nuclear Cardiology R&D Laboratory
    Emory University Hospital, Atlanta, Georgia 

    No CME or CE credit is provided.

  • Best Practices for Technologists

    Contains 1 Component(s) Recorded On: 06/21/2018

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the second in a series of complimentary webinars. These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    image

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the second in a series of complimentary webinars on Wednesday, June 20th at 9:00 PM (PT). These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    Faculty:

    E. Gordon DePuey, M.D., MASNC
    Director of Nuclear Medicine, Mount Sinai St. Luke's and West Hospitals
    Clinical Professor of Radiology, Icahn School of Medicine at Mount Sinai New York, NY

    Jereme Morley, CNMT, R.T. (CT)
    Chief Technologist, Nuclear Medicine, Mount Sinai St. Luke's Hospital New York, NY

    No CME or CE credit is provided.

  • Quality & Nuclear Cardiology: Importance to Technologists

    Contains 1 Component(s) Recorded On: 04/26/2018

    ASNC is pleased to offer a webinar for technologists on Quality & Nuclear Cardiology: Importance to Technologists. Attendees will be provided an understanding of what quality means in the current healthcare environment.

    ASNC is pleased to offer a webinar for technologists on Quality & Nuclear Cardiology: Importance to Technologists. Attendees will be provided an understanding of what quality means in the current healthcare environment.

    Objectives:
    This informative 60-minute webinar will help you:

    1.       Discuss the basic principles and theory of quality in healthcare
    2.       Discuss how quality is applied to imaging procedures
    3.       Discuss the humanistic factors affecting quality
    4.       Discuss the role of the nuclear medicine technologist in achieving a high quality interpretable image to drive patient care, outcomes and treatment

    Audience:
    This webinar is designed for imaging professionals interested in the best practices and latest research available in the field of nuclear cardiology.

    Program Chair
    April Mann, MBA, CNMT, NCT, RT(N), MASNC, FSNMMI-TS

    System Quality Manager
    Heart and Vascular Institute
    Hartford Healthcare Corporation
    Hartford, CT

    Planners
    April Mann, MBA, CNMT, NCT, RT(N), MASNC, FSNMMI-TS
    Wendy Passerell, ASNC Staff

    Reviewer
    April Mann, MBA, CNMT, NCT, RT(N), MASNC, FSNMMI-TS

    Disclosure Policy
    As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s 2004 Standards for Commercial Support.  In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through the disclosure of relevant financial relationship with commercial companies and resolution of conflicts of interest.  The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers and presenters involved with this activity were required to disclose any relevant financial relationships. The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and resolved or managed all identified conflicts of interest through a peer review process.

    The following faculty planners, reviewers, editors, question writers and staff reported the following financial relationships:
    April Mann, MBA, CNMT, NCT, RT(N), MASNC, FSNMMI-TS, Chair, Consulting – Jubilant DraxImage; Honoraria – Jubilant DraxImage, Astellas; Advisory Board – Astellas; Speaker’s Bureau – Astellas.

    The following faculty planners, reviewers, editors, question writers and staff reported no financial relationships:
    Wendy Passerell, ASNC staff

    Off Label Use
    Presentations may include discussion of drugs or devices, or uses of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented.  Presenters are required to disclose to the learners, if there is any off-label usage within the presentation.

    Accreditation and Continuing Education Credit

    Technologists: The American Society of Nuclear Cardiology is a recognized provider of continuing education credit for technologists. ASNC’s Continuing Education (CE) credit is accepted by both NMTCB and ARRT. This enduring activity has been approved for a maximum of 1 ARRT Category A credits for Technologists.

    Processing Fees
    ASNC members may claim continuing education credits at no charge.  Non-members will be charged $25.00 per activity.

    Method of Participation
    This enduring material is a 60-minute webinar. In order to be eligible for CE credit, you must listen to the webinar, reflect on the material and respond to the post-test. A score of 75% or higher is needed to pass the post-test. After successfully completing the activity, post-test and evaluation form, users will be able to generate an CE certificate.

    It is estimated that this activity will take 1 hour to complete.

    This is available as an online activity with audio synchronized with PowerPoint presentations.

    Policy of Privacy and Confidentiality
    ASNC will record learner’s personal information as provided on CE evaluations to allow for issuance and tracking of CE certificates. ASNC may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CE program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

    ASNC Copyright Information
    Please see the “Terms of Use” at the bottom of any asnc.org web page.

    Acknowledgement of Commercial Support
    This activity does not have commercial support.

    Learners’ Bill of Rights
    Please click to access Learners’ Bill of Rights.

    Contact Information
    For technical assistance or information, please contact CECity at lifetimesupport@premierinc.com

    For questions regarding content or obtaining CE credit, please contact the American Society of Nuclear Cardiology at info@asnc.org.

  • Cardio-Oncology: Therapeutic and diagnostic considerations of radiation exposure in breast cancer

    Contains 1 Component(s) Recorded On: 04/12/2018

    This webinar will review the concerns about cardiac complications of cancer therapy from the viewpoint of the oncologist and cardiologist. The discussion will specifically focus on the diagnostic and therapeutic uses of radiation and radionuclides in the care of cancer patients.

    image

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the first in a series of complimentary webinars on Wednesday, April 11th at 9:00 PM (PT). These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    Learning Objectives:                                                                                                                                                                            

    This webinar will review the concerns about cardiac complications of cancer therapy from the viewpoint of the oncologist and cardiologist. The discussion will specifically focus on the diagnostic and therapeutic uses of radiation and radionuclides in the care of cancer patients. 


    Faculty:  

    Raymond Russell, III, MD, PhD, MASNC
    Lifespan Cardiovascular Institute, Providence, RI
    Director, Nuclear Cardiology and Clinical Cardiology Fellowship Program

    Maysa Abu-Khalaf, MD
    Associate Professor of Medical Oncology
    Director, Breast Medical Oncology
    Co-Director, Jefferson Breast Care Center
    Sidney Kimmel Cancer Center at Jefferson

    No CME or CE credit is provided.

  • Clinical Quantification of Myocardial Blood Flow Using PET

    Contains 1 Component(s) Recorded On: 03/21/2018

    This webinar is designed for imaging professionals interested in the best practices and latest research available in the field of nuclear cardiology.

    Provided by the American Society of Nuclear Cardiology in Collaboration with the Society of Nuclear Medicine and Molecular Imaging  

    ASNC is pleased to offer a webinar on the Clinical Quantification of Myocardial Blood Flow Using PET. Attendees will increase their competence in the application of newly published guidelines for the performance of nuclear cardiology procedures. 

    Objectives:

    This informative 60-minute webinar will help you:  

    • Review differences between radiopharmaceuticals available for clinical myocardial perfusion PET imaging
    • Understand key technical aspects about imaging protocols and post-processing of multi-frame PET data for myocardial blood flow quantification, and how to troubleshoot artifacts
    • Review the pathophysiologic implications of quantitative myocardial blood flow and flow reserve data
    • Provide a case-based discussion of clinical scenarios for an effective inclusion of quantitative flow data into clinical reports
    • Discuss what quantitative data should be included and understand potential management implications of such data

    Audience:

    This webinar is designed for imaging professionals interested in the best practices and latest research available in the field of nuclear cardiology. 

    In addition, a 10-to-15 minute period has been reserved at the end of the speaker presentations for an interactive question-and-answer session so you can discuss specific issues or gain additional knowledge about topics discussed. 

    This activity is supported by an educational grant from Ionetix Corporation.

    Program Chair
    Marcelo F Di Carli, MD
    Brigham and Women’s Hospital
    Division of Nuclear Medicine
    Department of Radiology
    75 Francis Street
    Boston, MA 02115

    Faculty
    Venkatesh L. Murthy, MD, PhD, FACC, FASNC

    Associate Professor of Medicine & Radiology
    Director of Cardiac PET Research
    University of Michigan
    Frankel Cardiovascular Center
    Division of Cardiovascular Medicine

    Rob Beanlands, MD, FRCPC, FASNC
    Vered Chair and Chief, Division of Cardiology
    Professor, Medicine (Cardiology)/Radiology
    Tier 1 University of Ottawa Cardiovascular Research Chair
    Director, National Cardiac PET Centre
    University of Ottawa Heart Institute Ottawa, Canada

    Planners
    Marcelo F. Di Carli, MD
    Wendy Passerell, ASNC Staff

    Reviewer
    Maria Sciammarella, MD

    Disclosure Policy
    As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s 2004 Standards for Commercial Support.  In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through the disclosure of relevant financial relationship with commercial companies and resolution of conflicts of interest.  The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers and presenters involved with this activity were required to disclose any relevant financial relationships. The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and resolved or managed all identified conflicts of interest through a peer review process.

    The following faculty planners, reviewers, editors, question writers and staff reported no financial relationships:
    Maria Sciammarella, MD
    Wendy Passerell, ASNC staff

    The following faculty planners, reviewers, editors, question writers and staff reported financial relationships:
    Marcelo F. Di Carli, MD: Research Grant – Spectrum Dynamics; Consulting fees – Sanofi and GE
    Venkatesh L. Murthy, MD, PhD, FACC, FASNC: Consulting – Ionetix; Honoraria – Ionetix; Research Grants – Siemens Medical Imaging, INVIA Medical Imaging Solutions; Advisory Board – Ionetix; Stock – General Electric, Cardinal Health, Ionetix
    Rob Beanlands, MD, FRCPC, FASNC: Research Grants – GE Healthcare, Lantheus Medical Imaging, Jubilant DRAXImage; Consulting – GE Healthcare, Lantheus Medical Imaging, Jubilant DRAXImage

    Off Label Use
    Presentations may include discussion of drugs or devices, or uses of drugs or devices, that have not been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice. ASNC is committed to the free exchange of medical education. Inclusion of any discussion in this program, including discussion on off-label uses, does not imply an endorsement by ASNC of the uses, products or techniques presented.  Presenters are required to disclose to the learners, if there is any off-label usage within the presentation.

    Accreditation and Continuing Education Credit 

    Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

    The American Society of Nuclear Cardiology designates this internet-based activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    Technologists: The American Society of Nuclear Cardiology is a recognized provider of continuing education credit for technologists. ASNC’s Continuing Education (CE) credit is accepted by both NMTCB and ARRT. This Journal-based activity has been approved for a maximum of 1 ARRT Category A credits for Technologists. 

    Processing Fees
    ASNC members may claim continuing education credits at no charge.  Non-members will be charged $75.00 per activity. 

    Method of Participation
    This enduring material is a 60-minute webinar. In order to be eligible for CME/CE credit, you must listen to the webinar, reflect on the material and respond to the post test. A score of 75% or higher is needed to pass the post-test. After successfully completing the activity, post-test and evaluation form, users will be able to generate a CME/CE certificate. 

    It is estimated that this activity will take 1 hour to complete.

    This is available as an online activity with audio synchronized with PowerPoint presentations. 

    Policy of Privacy and Confidentiality
    ASNC will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. ASNC may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties. 

    ASNC Copyright Information
    Please see the “Terms of Use” at the bottom of any asnc.org web page. 

    Acknowledgement of Commercial Support
    This activity is supported by an educational grant from Ionetix Corporation.

    Learners’ Bill of Rights
    Please click to access Learners’ Bill of Rights.

    Contact Information
    For technical assistance or information, please contact CECity at lifetimesupport@premierinc.com

    For questions regarding CME content or obtaining CME credit, please contact the American Society of Nuclear Cardiology at info@asnc.org.

  • ASNC Advocacy: Quality Payment Program - What you need to know for 2018

    Contains 1 Component(s) Recorded On: 01/31/2018

    ASNC will provide an update to changes for CY2018 in the Merit Based Incentive Payment System and other provisions of the Quality Payment rule.

    Some of the rules for participating in the Quality Payment Program for 2018 have changed.  Learn what you need to know to avoid a negative payment update and how you could possibly earn an incentive in 2020.   

    For physicians and group practices that choose to participate in the Quality Payment Program through the Merit-Based Incentive Payment System (MIPS) pathway, the webinar will feature an overview of ASNC’s ImageGuide which is a qualified reporting mechanism that nuclear cardiologists can use to fulfill the quality component of the MIPS. 

    Speakers: Camille Bonta, MHS, Summit Health Consulting and Joe Reyes, ASNC Specialist, ImageGuide

  • Coding for Myocardial Blood Flow in PET

    Contains 1 Component(s) Recorded On: 01/24/2018

    This webinar will instruct attendees on the importance of proper billing and coding for Quantitation of Myocardial Blood Flow. There will also be a review pertinent changes to the chargemaster and other payment information.

    ASNC is pleased to announce a new category III code for absolute quantitation of Myocardial Blood Flow in PET effective Jan. 1, 2018. This webinar will instruct attendees on the importance of proper billing and coding for Quantitation of Myocardial Blood Flow. There will also be a review of pertinent changes to the chargemaster and other payment information.

    Speaker: Denise Merlino, MBA, CNMT, CPC, President of Merlino Health Consulting

  • Nuclear Cardiology in the Arab World, Challenges and Opportunities

    Contains 1 Component(s) Recorded On: 10/10/2017

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the third in a series of complimentary webinars on Tuesday, October 10th 11:00 AM (ET) – 12:00 PM (ET). These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    image

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the third in a series of complimentary webinars on Tuesday, October 10th 11:00 AM (ET) – 12:00 PM (ET). These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians. 

    Webinar in Arabic and English on “Nuclear Cardiology in the Arab World, Challenges and Opportunities

    Faculty:

    Mouaz H. Al-Mallah, MD MSc, FASNC FACC FAHA FESC
    Associate Professor of Medicine
    Consultant Cardiologist and Division Head, Cardiac Imaging
    King Abdul-Aziz Cardiac Center
    King Abdul-Aziz Medical City (Riyadh)

    Adel H Allam, MD, FASNC
    Professor of Cardiology Al Azhar University
    Chief of Nuclear Cardiology Alfa Medical
    President of the Egyptian League of Cardiovascular Imaging

    No CME or CE credit is provided for this event.

  • Clinical Indications of PET for Myocardial Perfusion PET

    Contains 1 Component(s) Recorded On: 07/27/2017

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the second in a series of complimentary webinars on Wednesday, July 26 at 9:00 PM (PT). These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    image

    The International Atomic Energy Agency (IAEA) and the American Society of Nuclear Cardiology (ASNC) bring you the second in a series of complimentary webinars on Wednesday, July 26 at 9:00 PM (PT). These webinars are designed to provide the best practices in Nuclear Cardiology to cardiologists, radiologists, technologists and nuclear medicine physicians.

    Webinar on “Clinical Indications of PET for Myocardial Perfusion PET”


    Speakers:

    Timothy Bateman, MD
    St. Luke’s Health System, University of Missouri- Kansas City School of Medicine, Kansas City, MO.

    Gary V. Heller, MD, PhD
    Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, NJ.

    James Case, PhD
    Cardiovascular Imaging Technologies,L.L.C., Kansas City, MO.  


    The session will be based on the American Society of Nuclear Cardiology and the Society of Nuclear Medicine and Molecular Imaging Position Statement on the Clinical Indications of PET for Myocardial Perfusion PET.  Attendees will increase their competency of myocardial perfusion PET and learn about the advantages of various PET imaging protocols.

    No CME or CE credit is provided for this event.